Insiders / Frazier Life Sciences VIII, L.P.
Frazier Life Sciences VIII, L.P.
CIK 1655827unknownbeneficial ownerinsider
Companies
2
First seen
Feb 4, 2021
Last activity
Aug 20, 2025
Securities
2 companies · 3 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Arcutis Biotherapeutics, Inc. · ARQT | 8,827,261 | — |
| Common stock | 8,827,261 | Oct 24, 2023 |
| Nivalis Therapeutics, Inc. · ALPN | 1,484,115 | — |
| Common stock | 1,484,115 | Feb 11, 2022 |
| Options | 1,200,000 | Sep 17, 2021 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 5, 2022 | Buy Open-market buy | ARQT Arcutis Biotherapeutics, Inc. Common Stock | $5.00M | +250K +2.96% | 8,684,232 6.91% of shares | high |
| Feb 11, 2022 | Buy Open-market buy | ALPN Nivalis Therapeutics, Inc. Common Stock | $800.0K | +113K +8.21% | 1,484,115 | high |
| Oct 24, 2023 | Buy Open-market buy | ARQT Arcutis Biotherapeutics, Inc. Common Stock | $200.0K | +80K +0.92% | 8,764,232 6.97% of shares | medium |
| May 10, 2021 |